Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.2200+0.3700 (+9.61%)
At close: 04:00PM EDT
4.0900 -0.13 (-3.08%)
After hours: 04:06PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/30/2022
Current
6/30/20223/31/202212/31/20219/30/2021
Market Cap (intraday)
342.54M735.03M867.74M1.44B1.58B
Enterprise Value
75.22M450.68M524.94M1.11B1.22B
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
4.9731.0242.78111.69211.22
Price/Book (mrq)
1.333.283.104.664.77
Enterprise Value/Revenue
1.058.7471.77147.33227.36
Enterprise Value/EBITDA
-0.26-14.68-6.06-12.23-14.80

Trading Information

Stock Price History

Beta (5Y Monthly) 0.95
52-Week Change 3-77.97%
S&P500 52-Week Change 3-15.36%
52 Week High 320.0400
52 Week Low 32.8300
50-Day Moving Average 34.0562
200-Day Moving Average 38.3228

Share Statistics

Avg Vol (3 month) 32.68M
Avg Vol (10 day) 31.66M
Shares Outstanding 594.36M
Implied Shares Outstanding 6N/A
Float 871.47M
% Held by Insiders 10.71%
% Held by Institutions 1107.83%
Shares Short (Sep 14, 2022) 412.35M
Short Ratio (Sep 14, 2022) 46.93
Short % of Float (Sep 14, 2022) 413.42%
Short % of Shares Outstanding (Sep 14, 2022) 413.08%
Shares Short (prior month Aug 14, 2022) 411.28M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-415.77%

Management Effectiveness

Return on Assets (ttm)-41.80%
Return on Equity (ttm)-84.09%

Income Statement

Revenue (ttm)71.81M
Revenue Per Share (ttm)0.73
Quarterly Revenue Growth (yoy)1,232.80%
Gross Profit (ttm)-229.6M
EBITDA -290.64M
Net Income Avi to Common (ttm)-247.65M
Diluted EPS (ttm)-3.6450
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)331.31M
Total Cash Per Share (mrq)3.51
Total Debt (mrq)74.67M
Total Debt/Equity (mrq)29.00
Current Ratio (mrq)5.28
Book Value Per Share (mrq)2.73

Cash Flow Statement

Operating Cash Flow (ttm)-241.74M
Levered Free Cash Flow (ttm)-163.32M
Advertisement
Advertisement